Clinical pharmacokinetics of a new antiandrogen Anandron (RU 23908).
Pendyala
L
L
Roswell Park Memorial Institute, Buffalo, New York.
Creaven
P J
PJ
Huben
R
R
Tremblay
D
D
Mouren
M
M
Bertagna
C
C
D000726:Androgen Antagonists / Q000493:pharmacokinetics*; D002250:Carbon Radioisotopes; D006207:Half-Life; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics*; D048289:Imidazolidines; D008297:Male; D008991:Monitoring, Physiologic
D000726:Androgen Antagonists; D002250:Carbon Radioisotopes; D007093:Imidazoles; D048289:Imidazolidines; C021277:nilutamide